Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Is Health Care's Hottest Stock a Mirage?

The markets have roared higher over the past year, but few stocks have had the kind of run-up that developmental 3-D bioprinting company Organovo Holdings (NYSEMKT: ONVO  ) has. Organovo's stock has jumped by more than 125% over the past year, but this company has yet to generate any meaningful revenue, and its bioprinting technology has only caught on with a few partnerships, most recently one with the NIH to print tissue for research purposes.

However, is trouble on the horizon? This week, noted short-selling site Citron Research sent out a warning to investors over Organovo's stock. Among other issues, Citron noted the stock's lack of sell-side coverage and significant institutional ownership in questioning how the stock's jumped so far so fast.

Is Citron on to something with Organovo? In the video below, Motley Fool contributor Dan Carroll tells you what you need to know about the latest news swirling around this hot stock -- and whether or not you can believe in Organovo's stock's rapid rise.

The two biotech stocks that could transform your portfolio's potential
Biotech can be a growth investor's dream. The best way to play the biotech space is to find companies that shun the status quo and instead discover revolutionary, groundbreaking technologies. In the Motley Fool's brand-new FREE report "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that big pharma is endorsing through partnerships, and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.

Read/Post Comments (2) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On January 24, 2014, at 6:55 PM, zijzoe wrote:

    This guy said absolutely nothing of value about Organovo. At best you'd think he was paid by Citron. I recommend that before Motley allows a hack to post they do ensure they are valid especially before they post a video have the do some DD and have an understanding about the company they're spouting about I'll take MIT's recommendation over this hacn and Citron.

  • Report this Comment On January 25, 2014, at 11:21 AM, Iamfool4mo wrote:

    Zijzoe. good point.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2807691, ~/Articles/ArticleHandler.aspx, 9/1/2015 4:33:17 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Dan Carroll

Dan began writing for the Motley Fool in 2012. He is a health care specialist who also follows the defense industry along with tracking the broader U.S. and international markets.

Today's Market

updated Moments ago Sponsored by:
DOW 16,058.35 -469.68 -2.84%
S&P 500 1,913.85 -58.33 -2.96%
NASD 4,636.11 -140.40 -2.94%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/1/2015 4:00 PM
ONVO $2.45 Down -0.28 -10.26%